Cargando…
Diagnosis and management of progressive ataxia in adults
Progressive ataxia in adults can be difficult to diagnose, owing to its heterogeneity and the rarity of individual causes. Many patients remain undiagnosed (‘idiopathic’ ataxia). This paper provides suggested diagnostic pathways for the general neurologist, based on Ataxia UK’s guidelines for profes...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6585307/ https://www.ncbi.nlm.nih.gov/pubmed/31048364 http://dx.doi.org/10.1136/practneurol-2018-002096 |
_version_ | 1783428681222324224 |
---|---|
author | de Silva, Rajith Nilantha Vallortigara, Julie Greenfield, Julie Hunt, Barry Giunti, Paola Hadjivassiliou, Marios |
author_facet | de Silva, Rajith Nilantha Vallortigara, Julie Greenfield, Julie Hunt, Barry Giunti, Paola Hadjivassiliou, Marios |
author_sort | de Silva, Rajith Nilantha |
collection | PubMed |
description | Progressive ataxia in adults can be difficult to diagnose, owing to its heterogeneity and the rarity of individual causes. Many patients remain undiagnosed (‘idiopathic’ ataxia). This paper provides suggested diagnostic pathways for the general neurologist, based on Ataxia UK’s guidelines for professionals. MR brain scanning can provide diagnostic clues, as well as identify ‘structural’ causes such as tumours and multiple sclerosis. Advances in molecular genetics, including the wider and cheaper availability of ‘next-generation sequencing’, have enabled clinicians to identify many more cases with a genetic cause. Finally, autoimmunity is probably an under-recognised cause of progressive ataxia: as well as patients with antigliadin antibodies there are smaller numbers with various antibodies, including some associated with cancer. There are a few treatable ataxias, but also symptomatic treatments to help people with the spectrum of complications that might accompany progressive ataxias. Multidisciplinary team involvement and allied health professionals’ input are critical to excellent patient care, including in the palliative phase. We can no longer justify a nihilistic approach to the management of ataxia. |
format | Online Article Text |
id | pubmed-6585307 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-65853072019-07-05 Diagnosis and management of progressive ataxia in adults de Silva, Rajith Nilantha Vallortigara, Julie Greenfield, Julie Hunt, Barry Giunti, Paola Hadjivassiliou, Marios Pract Neurol Review Progressive ataxia in adults can be difficult to diagnose, owing to its heterogeneity and the rarity of individual causes. Many patients remain undiagnosed (‘idiopathic’ ataxia). This paper provides suggested diagnostic pathways for the general neurologist, based on Ataxia UK’s guidelines for professionals. MR brain scanning can provide diagnostic clues, as well as identify ‘structural’ causes such as tumours and multiple sclerosis. Advances in molecular genetics, including the wider and cheaper availability of ‘next-generation sequencing’, have enabled clinicians to identify many more cases with a genetic cause. Finally, autoimmunity is probably an under-recognised cause of progressive ataxia: as well as patients with antigliadin antibodies there are smaller numbers with various antibodies, including some associated with cancer. There are a few treatable ataxias, but also symptomatic treatments to help people with the spectrum of complications that might accompany progressive ataxias. Multidisciplinary team involvement and allied health professionals’ input are critical to excellent patient care, including in the palliative phase. We can no longer justify a nihilistic approach to the management of ataxia. BMJ Publishing Group 2019-06 2019-05-02 /pmc/articles/PMC6585307/ /pubmed/31048364 http://dx.doi.org/10.1136/practneurol-2018-002096 Text en © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Review de Silva, Rajith Nilantha Vallortigara, Julie Greenfield, Julie Hunt, Barry Giunti, Paola Hadjivassiliou, Marios Diagnosis and management of progressive ataxia in adults |
title | Diagnosis and management of progressive ataxia in adults |
title_full | Diagnosis and management of progressive ataxia in adults |
title_fullStr | Diagnosis and management of progressive ataxia in adults |
title_full_unstemmed | Diagnosis and management of progressive ataxia in adults |
title_short | Diagnosis and management of progressive ataxia in adults |
title_sort | diagnosis and management of progressive ataxia in adults |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6585307/ https://www.ncbi.nlm.nih.gov/pubmed/31048364 http://dx.doi.org/10.1136/practneurol-2018-002096 |
work_keys_str_mv | AT desilvarajithnilantha diagnosisandmanagementofprogressiveataxiainadults AT vallortigarajulie diagnosisandmanagementofprogressiveataxiainadults AT greenfieldjulie diagnosisandmanagementofprogressiveataxiainadults AT huntbarry diagnosisandmanagementofprogressiveataxiainadults AT giuntipaola diagnosisandmanagementofprogressiveataxiainadults AT hadjivassilioumarios diagnosisandmanagementofprogressiveataxiainadults |